Open Access. Powered by Scholars. Published by Universities.®
- Keyword
-
- Acute mesenteric ischemia (1)
- Artificial Intelligence (1)
- Chronic mesenteric ischemia (1)
- Colon ischemia (1)
- Curriculum (1)
-
- Division of Gastroenterology and Hepatology (1)
- Education (1)
- Education, Medical (1)
- Endovascular treatment of acute (1)
- Humans (1)
- Ischemic colitis (1)
- Learning (1)
- Liver Disease Prevention Center; Division of Gastroenterology and Hepatology; Department of Medicine (1)
- Medical (1)
- Students (1)
- Thomas Jefferson University Hospital; Androgens; Chronic hepatitis B; Estrogens; Gender disparity; Hepatitis B virus; Hepatocellular carcinoma; Prognosis; Sex difference; Stress; Survival (1)
- Thomas Jefferson University; biologic; emerging therapy; inflammatory bowel disease; novel therapy; small molecule (1)
Articles 1 - 4 of 4
Full-Text Articles in Medicine and Health Sciences
Ischemic Bowel Disease In 2021, Monjur Ahmed
Ischemic Bowel Disease In 2021, Monjur Ahmed
Division of Gastroenterology and Hepatology Faculty Papers
Ischemic bowel disease (ISBODI) includes colon ischemia, acute mesenteric ischemia (AMI) and chronic mesenteric ischemia (CMI). Epidemiologically, colon ischemia is the most common type followed by AMI and CMI. There are various risk factors for the development of ISBODI. Abdominal pain is the common presenting symptom of each type. High clinical suspicion is essential in ordering appropriate tests. Imaging studies and colonoscopy with biopsy are the main diagnostic tests. Treatment varies from conservative measures to surgical resection and revascularization. Involvement of multidisciplinary team is essential in managing ISBODI. Although open surgery with revascularization plays an important role, recently there is …
Gender Disparity In Host Responses To Hepatitis B-Related Hepatocellular Carcinoma: A Case Series, Rukaiya Bashir-Hamidu, Divya Chalikonda, Hie-Won Hann
Gender Disparity In Host Responses To Hepatitis B-Related Hepatocellular Carcinoma: A Case Series, Rukaiya Bashir-Hamidu, Divya Chalikonda, Hie-Won Hann
Division of Gastroenterology and Hepatology Faculty Papers
Chronic hepatitis B virus (HBV) infection is one of the most common causes of hepato-cellular carcinoma (HCC), a malignant tumor with high mortality worldwide. One remarkable clinical feature of HBV-related HCC is that the risk of development is higher in males and post-menopausal females compared to other females. Increasing evidence also indicates that the prognosis of HBV-associated HCC may involve gender disparity, with females having more favorable out-comes. The proposed mechanism of this gender disparity is thought to be complex and multifactorial. Attributions have been made to gender differences in behavioral risk factors, host stress, immune response, psychology, metabolic risk …
Exploiting The Power Of Information In Medical Education., William B. Cutrer, W. Anderson Spickard, Marc M. Triola, Bradley L. Allen, Nathan Spell, Steven K. Herrine, John L. Dalrymple, Paul N. Gorman, Kimberly D. Lomis
Exploiting The Power Of Information In Medical Education., William B. Cutrer, W. Anderson Spickard, Marc M. Triola, Bradley L. Allen, Nathan Spell, Steven K. Herrine, John L. Dalrymple, Paul N. Gorman, Kimberly D. Lomis
Division of Gastroenterology and Hepatology Faculty Papers
The explosion of medical information demands a thorough reconsideration of medical education, including what we teach and assess, how we educate, and whom we educate. Physicians of the future will need to be self-aware, self-directed, resource-effective team players who can synthesize and apply summarized information and communicate clearly. Training in metacognition, data science, informatics, and artificial intelligence is needed. Education programs must shift focus from content delivery to providing students explicit scaffolding for future learning, such as the Master Adaptive Learner model. Additionally, educators should leverage informatics to improve the process of education and foster individualized, precision education. Finally, attributes …
Novel And Emerging Therapies For Inflammatory Bowel Disease., Badr Al-Bawardy, Raina Shivashankar, Deborah D Proctor
Novel And Emerging Therapies For Inflammatory Bowel Disease., Badr Al-Bawardy, Raina Shivashankar, Deborah D Proctor
Division of Gastroenterology and Hepatology Faculty Papers
Inflammatory bowel diseases (IBD) such as ulcerative colitis and Crohn's disease are chronic, relapsing and remitting disorders of intestinal inflammation with potential systemic manifestations. Despite the availability of current biologics, such as anti-tumor necrosis factor (anti-TNF), anti-integrins, anti-interleukins and small molecules such as tofacitinib, the rates of primary and secondary treatment failure remain high in IBD. This highlights the importance of continued development of new therapeutic targets and modifications of existing ones to improve the treatment response rates and to also improve the safety profile and tolerability of these medications. In this review we will discuss novel treatment target agents …